Literature DB >> 24006669

[Effect of acupoint catgut embedding on motor function and serum high sensitivity C-reactive protein and IL-6 levels in patients with acute cerebral infarction].

Ai-Song Guo1, Ai-Hong Li, Xin Chen, Wei-Guan Chen, Li Sun.   

Abstract

OBJECTIVE: To evaluate the effect of acupoint catgut embedding on motor function in patients with acute cerebral infarction (ACI), and to explore its mechanism.
METHODS: Sixty-three ACI patients were randomly assigned to acupuncture group (n = 30) and catgut embedding group (n = 33). Patients of the acupuncture group received acupuncture stimulation of Baihui (GV 20), Neiguan (P 6), Sanyinjiao (SP 6), Taichong (LR 3), etc. and scalp-point Motor Area, Sensory Area, Balance Area, once daily, 5 times a week for 20 times. Patients of the catgut embedding group received catgut embedding at the acupoints same to acupuncture group, once every 10 days, 3 times altogether. Additionally, both groups received regular treatment of neurology (controlling blood pressure, blood sugar and blood lipids levels, physical therapy, etc.) and early rehabilitation training (limb otor training). The patients' functional mobility was evaluated by simplified Fugl-Meyer Assessment Scale (FMA) and Modified Bathel Index Scale (MBI). The level of serum high sensitivity C-reactive protein (hs-CRP) was detected using latex agglutination reaction method; and serum in terleukin-6 (IL-6) content measured by enzyme-linked immunosorbent assay.
RESULTS: lts After 30 days' treatment, the mean scores of FMA and MBI were significantly increased in both acupuncture group and catgut embedding grou p (P < 0.05), suggesting an improvement of the cerebral infarction patient's functional mobility after the treatment. The therapeutic effect of the catgut embedding was obviously superior to that of the acupuncture grou p (P < 0. 05). The mean contents of serum IL-6 and hs-CRP of the two groups were significantly decreased after the treatmen t (P < 0.05), suggesting a reduction of proinflammatory cytokine and inflammatory mediator levels, respectively. The levels of both serum IL-6 and hs-CRP of the catgut embedding group were markedly lower than those of the acupuncture group ( P < 0.05).
CONCLUSION: ion Acupoint catgut embedding therapy is effective in improving cerebral infarction patients' functional mobility, which is related to its action in inhibiting inflammatory reaction in the early stage of cerebral ischemic injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006669

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  5 in total

1.  Clinical significance of interleukin-6, tumor necrosis factor-α and high-sensitivity C-reactive protein in neonates with hypoxic-ischemic encephalopathy.

Authors:  Yun Shang; Lina Mu; Xixia Guo; Yuhua Li; Limin Wang; Weihong Yang; Shujun Li; Qiong Shen
Journal:  Exp Ther Med       Date:  2014-07-29       Impact factor: 2.447

Review 2.  Remote Ischemic Postconditioning for Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Jing-Jing Zhao; Hui Xiao; Wen-Bo Zhao; Xiao-Pei Zhang; Yu Xiang; Zeng-Jie Ye; Miao-Miao Mo; Xue-Ting Peng; Lin Wei
Journal:  Chin Med J (Engl)       Date:  2018-04-20       Impact factor: 2.628

3.  Acupoint Catgut Embedding Improves the Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats.

Authors:  Dan Li; Tian Sun; Laiting Chi; Dengming Zhao; Wenzhi Li
Journal:  Biomed Res Int       Date:  2020-05-02       Impact factor: 3.411

4.  Association between serum lipoprotein levels and neurological function in patients with acute ischemic stroke: A protocol of systematic review and meta-analysis.

Authors:  Yao-Jia Jiang; Zeng-Mian Wang; Ze-Yu Wang; Chun-Jie Wei
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

5.  Effect of Edaravone Combined with Anticoagulant Therapy on the Serum hs-CRP, IL-6, and TNF-α Levels and Activity of Daily Living in Patients with Acute Cerebral Infarction.

Authors:  Chao Sun; Cuiling Ma; Yu Sun; Lili Ma
Journal:  J Healthc Eng       Date:  2022-02-28       Impact factor: 2.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.